Pharmacogenomics with antidepressants in the STAR*D study.
about
Machine learning and systems genomics approaches for multi-omics data.Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorderFunctional biomarkers of depression: diagnosis, treatment, and pathophysiologySexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.Association study of a brain-derived neurotrophic-factor polymorphism and short-term antidepressant response in major depressive disorders.Strategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptoms.Pharmacogenetics of selective serotonin reuptake inhibitors in pediatric depression and anxiety.Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.Pharmacogenetic considerations in the treatment of psychiatric disorders.Why, when, and how should pharmacogenetics be applied in clinical studies?: current and future approaches to study designs.Treatment-resistant depression in adolescents: review and updates on clinical management.Recent advances in bipolar disorder pharmacotherapy: focus on bipolar depression and rapid cycling.Assessing gene-gene interactions in pharmacogenomics.Animal models for depression associated with HIV-1 infection.Genome-wide association studies in pharmacogenomics of antidepressants.Pharmacogenomic testing and outcome among depressed patients in a tertiary care outpatient psychiatric consultation practice.Influence of genetic polymorphisms in the glutamatergic and GABAergic systems and their interactions with environmental stressors on antidepressant response.Biomarkers for Major Depressive Disorder: Economic Considerations.Seeking an objective diagnosis of depression.TPH1 is associated with major depressive disorder but not with SSRI/SNRI response in Taiwanese patients.
P2860
Q31157242-B6FEBCC9-A1B7-46B3-8CD5-E9E4EB05C4D4Q33913645-597713D4-2D03-4516-B754-9EAC1736DB31Q35356872-294A0BC1-8DF4-443A-A7D5-0794FAEEF195Q35755912-94166A70-650C-4B20-8A06-344053298CF0Q36441426-C1990310-82A9-4F39-9289-2F897CC76AB5Q37289129-E4A2E148-CF1E-44E2-8668-41DBCAB8F5EAQ37329171-43A8F631-CF31-44D2-9FFA-F1A23F3314F5Q37678047-5E5DCE0F-24DD-4B08-A169-8D011CEF3C9DQ37681573-AF2914F4-07EE-4E33-A8FE-DAB56480D268Q37826340-8E767F29-EE67-4209-8325-3AF8C778B406Q37928596-86E0C20F-EC67-4F6C-AA74-CCBAB548E52BQ37960184-74D8E0DE-42DF-4FDA-965F-ADCB726AFAB7Q37986775-77079925-21AD-4E4E-B823-696A22A47793Q38171363-E503FF65-EFEB-4867-AA5D-C6E4D60BCBD8Q38444447-C9DCE08E-3934-45E5-970D-D8397E3C2F53Q42574315-C3DE84E4-9234-41A1-A73C-EAB3E4391D00Q45949305-BB953DD5-4328-431A-8090-6F50057522FCQ47671635-F978919A-B178-454E-AB52-C2E9FCB528A9Q48048867-8ECE6C6E-A2F7-4FEA-BD0D-7AB290FE2245Q48987609-770C88C2-D355-4597-863A-871FB261CDA8
P2860
Pharmacogenomics with antidepressants in the STAR*D study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacogenomics with antidepressants in the STAR*D study.
@en
Pharmacogenomics with antidepressants in the STAR*D study.
@nl
type
label
Pharmacogenomics with antidepressants in the STAR*D study.
@en
Pharmacogenomics with antidepressants in the STAR*D study.
@nl
prefLabel
Pharmacogenomics with antidepressants in the STAR*D study.
@en
Pharmacogenomics with antidepressants in the STAR*D study.
@nl
P2860
P356
P1433
P1476
Pharmacogenomics with antidepressants in the STAR*D study.
@en
P2093
Eugene Lin
Po See Chen
P2860
P304
P356
10.2217/14622416.9.7.935
P577
2008-07-01T00:00:00Z